Perficient: Drug Development

NOVEMBER 26, 2023

Communication is a fundamental aspect of human connection and expression, yet for individuals with seizure disabilities, challenges in verbal communication can present significant barriers. The advent of assistive technology has ushered in a new era of possibilities, offering an array of communication aids designed to empower those facing seizure-related communication challenges.

Production 52

Production Marketing 52

Covalent Modifiers

NOVEMBER 26, 2023

Ziyang Zhang, Johannes Morstein, Andrew K. Ecker, Keelan Z. Guiley, and Kevan M. Shokat Journal of the American Chemical Society 2022 144 (35), 15916-15921 DOI: 10.1021/jacs.2c05377 KRAS mutations are one of the most common oncogenic drivers in human cancer. While small molecule inhibitors for the G12C mutant have been successfully developed, allele-specific inhibition for other KRAS hotspot mutants remains challenging.

Small Molecule 52

Small Molecule Therapies Production 52

Perficient: Drug Development

NOVEMBER 26, 2023

In the pursuit of inclusive and equitable societies, the intersection of educational assistive technology and employment opportunities plays a pivotal role, especially for individuals with seizure disabilities. Empowering individuals through education and leveraging assistive technology in the workplace not only fosters independence but also opens doors to diverse and fulfilling career paths.

Production 52

Production Marketing 52

Drug Patent Watch

NOVEMBER 26, 2023

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Lithuania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating… The post Which pharmaceutical companies have the most SPCs in Lithuania? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceuticals 59

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Perficient: Drug Development

NOVEMBER 26, 2023

For individuals living with seizure disabilities, the home environment plays a crucial role in fostering safety and independence. Thanks to advancements in smart home technology, creating a seizure-friendly living space has become more achievable than ever. In this blog post, we will explore the transformative impact of smart home adaptations on the lives of those with seizure disabilities, enhancing both safety and quality of life.

Production 52

Production Marketing 52

Drug & Device Law

NOVEMBER 26, 2023

We hope our loyal readers had a wonderful Thanksgiving. As you reflect on what you’re thankful for this year, we would like to suggest one more item for your list: Discounted registration to ACI’s Drug and Medical Device Litigation Conference , coming up on December 5-6. As we mentioned, the good people at ACI asked the blog to be a media sponsor this year – and are offering a special registration discount for the conference for the blog’s readers.

Drugs 52

Drugs 52